Matuzumab Market, Global Outlook and Forecast 2022-2028
Matuzumab (formerly known as the experimental drug, EMD 72000) is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
This report contains market size and forecasts of Matuzumab in global, including the following market information:
Global Matuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Matuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Matuzumab companies in 2021 (%)
The global Matuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Matuzumab include Biosynth Carbosynth, BOC Sciences, Carbosynth, Merck KGaA, Shanghai Yifei Biotechnology, Takeda Pharmaceutical, TargetMol Chemicals, Wonda Science and Hangzhou Dayangchem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Matuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Matuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Matuzumab Market Segment Percentages, by Type, 2021 (%)
Global Matuzumab Market Segment Percentages, by Application, 2021 (%)
Global Matuzumab Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Matuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Matuzumab revenues share in global market, 2021 (%)
Key companies Matuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Matuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Matuzumab in global, including the following market information:
Global Matuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Matuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Matuzumab companies in 2021 (%)
The global Matuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Matuzumab include Biosynth Carbosynth, BOC Sciences, Carbosynth, Merck KGaA, Shanghai Yifei Biotechnology, Takeda Pharmaceutical, TargetMol Chemicals, Wonda Science and Hangzhou Dayangchem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Matuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Matuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Matuzumab Market Segment Percentages, by Type, 2021 (%)
- Patent
- Generic
Global Matuzumab Market Segment Percentages, by Application, 2021 (%)
- Chemical
- Pharmaceutical
Global Matuzumab Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Matuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Matuzumab revenues share in global market, 2021 (%)
Key companies Matuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Matuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biosynth Carbosynth
- BOC Sciences
- Carbosynth
- Merck KGaA
- Shanghai Yifei Biotechnology
- Takeda Pharmaceutical
- TargetMol Chemicals
- Wonda Science
- Hangzhou Dayangchem
- Leap Chem
- Nantong Feiyu Biological Technology
- Ningbo Inno Pharmchem
- Sichuan Weiqi Biotechnology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Matuzumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Matuzumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MATUZUMAB OVERALL MARKET SIZE
2.1 Global Matuzumab Market Size: 2021 VS 2028
2.2 Global Matuzumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Matuzumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Matuzumab Players in Global Market
3.2 Top Global Matuzumab Companies Ranked by Revenue
3.3 Global Matuzumab Revenue by Companies
3.4 Global Matuzumab Sales by Companies
3.5 Global Matuzumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Matuzumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Matuzumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Matuzumab Players in Global Market
3.8.1 List of Global Tier 1 Matuzumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Matuzumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Matuzumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Matuzumab Revenue & Forecasts
4.2.1 By Type - Global Matuzumab Revenue, 2017-2022
4.2.2 By Type - Global Matuzumab Revenue, 2023-2028
4.2.3 By Type - Global Matuzumab Revenue Market Share, 2017-2028
4.3 By Type - Global Matuzumab Sales & Forecasts
4.3.1 By Type - Global Matuzumab Sales, 2017-2022
4.3.2 By Type - Global Matuzumab Sales, 2023-2028
4.3.3 By Type - Global Matuzumab Sales Market Share, 2017-2028
4.4 By Type - Global Matuzumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Matuzumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Matuzumab Revenue & Forecasts
5.2.1 By Application - Global Matuzumab Revenue, 2017-2022
5.2.2 By Application - Global Matuzumab Revenue, 2023-2028
5.2.3 By Application - Global Matuzumab Revenue Market Share, 2017-2028
5.3 By Application - Global Matuzumab Sales & Forecasts
5.3.1 By Application - Global Matuzumab Sales, 2017-2022
5.3.2 By Application - Global Matuzumab Sales, 2023-2028
5.3.3 By Application - Global Matuzumab Sales Market Share, 2017-2028
5.4 By Application - Global Matuzumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Matuzumab Market Size, 2021 & 2028
6.2 By Region - Global Matuzumab Revenue & Forecasts
6.2.1 By Region - Global Matuzumab Revenue, 2017-2022
6.2.2 By Region - Global Matuzumab Revenue, 2023-2028
6.2.3 By Region - Global Matuzumab Revenue Market Share, 2017-2028
6.3 By Region - Global Matuzumab Sales & Forecasts
6.3.1 By Region - Global Matuzumab Sales, 2017-2022
6.3.2 By Region - Global Matuzumab Sales, 2023-2028
6.3.3 By Region - Global Matuzumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Matuzumab Revenue, 2017-2028
6.4.2 By Country - North America Matuzumab Sales, 2017-2028
6.4.3 US Matuzumab Market Size, 2017-2028
6.4.4 Canada Matuzumab Market Size, 2017-2028
6.4.5 Mexico Matuzumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Matuzumab Revenue, 2017-2028
6.5.2 By Country - Europe Matuzumab Sales, 2017-2028
6.5.3 Germany Matuzumab Market Size, 2017-2028
6.5.4 France Matuzumab Market Size, 2017-2028
6.5.5 U.K. Matuzumab Market Size, 2017-2028
6.5.6 Italy Matuzumab Market Size, 2017-2028
6.5.7 Russia Matuzumab Market Size, 2017-2028
6.5.8 Nordic Countries Matuzumab Market Size, 2017-2028
6.5.9 Benelux Matuzumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Matuzumab Revenue, 2017-2028
6.6.2 By Region - Asia Matuzumab Sales, 2017-2028
6.6.3 China Matuzumab Market Size, 2017-2028
6.6.4 Japan Matuzumab Market Size, 2017-2028
6.6.5 South Korea Matuzumab Market Size, 2017-2028
6.6.6 Southeast Asia Matuzumab Market Size, 2017-2028
6.6.7 India Matuzumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Matuzumab Revenue, 2017-2028
6.7.2 By Country - South America Matuzumab Sales, 2017-2028
6.7.3 Brazil Matuzumab Market Size, 2017-2028
6.7.4 Argentina Matuzumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Matuzumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Matuzumab Sales, 2017-2028
6.8.3 Turkey Matuzumab Market Size, 2017-2028
6.8.4 Israel Matuzumab Market Size, 2017-2028
6.8.5 Saudi Arabia Matuzumab Market Size, 2017-2028
6.8.6 UAE Matuzumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Biosynth Carbosynth
7.1.1 Biosynth Carbosynth Corporate Summary
7.1.2 Biosynth Carbosynth Business Overview
7.1.3 Biosynth Carbosynth Matuzumab Major Product Offerings
7.1.4 Biosynth Carbosynth Matuzumab Sales and Revenue in Global (2017-2022)
7.1.5 Biosynth Carbosynth Key News
7.2 BOC Sciences
7.2.1 BOC Sciences Corporate Summary
7.2.2 BOC Sciences Business Overview
7.2.3 BOC Sciences Matuzumab Major Product Offerings
7.2.4 BOC Sciences Matuzumab Sales and Revenue in Global (2017-2022)
7.2.5 BOC Sciences Key News
7.3 Carbosynth
7.3.1 Carbosynth Corporate Summary
7.3.2 Carbosynth Business Overview
7.3.3 Carbosynth Matuzumab Major Product Offerings
7.3.4 Carbosynth Matuzumab Sales and Revenue in Global (2017-2022)
7.3.5 Carbosynth Key News
7.4 Merck KGaA
7.4.1 Merck KGaA Corporate Summary
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Matuzumab Major Product Offerings
7.4.4 Merck KGaA Matuzumab Sales and Revenue in Global (2017-2022)
7.4.5 Merck KGaA Key News
7.5 Shanghai Yifei Biotechnology
7.5.1 Shanghai Yifei Biotechnology Corporate Summary
7.5.2 Shanghai Yifei Biotechnology Business Overview
7.5.3 Shanghai Yifei Biotechnology Matuzumab Major Product Offerings
7.5.4 Shanghai Yifei Biotechnology Matuzumab Sales and Revenue in Global (2017-2022)
7.5.5 Shanghai Yifei Biotechnology Key News
7.6 Takeda Pharmaceutical
7.6.1 Takeda Pharmaceutical Corporate Summary
7.6.2 Takeda Pharmaceutical Business Overview
7.6.3 Takeda Pharmaceutical Matuzumab Major Product Offerings
7.6.4 Takeda Pharmaceutical Matuzumab Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Key News
7.7 TargetMol Chemicals
7.7.1 TargetMol Chemicals Corporate Summary
7.7.2 TargetMol Chemicals Business Overview
7.7.3 TargetMol Chemicals Matuzumab Major Product Offerings
7.7.4 TargetMol Chemicals Matuzumab Sales and Revenue in Global (2017-2022)
7.7.5 TargetMol Chemicals Key News
7.8 Wonda Science
7.8.1 Wonda Science Corporate Summary
7.8.2 Wonda Science Business Overview
7.8.3 Wonda Science Matuzumab Major Product Offerings
7.8.4 Wonda Science Matuzumab Sales and Revenue in Global (2017-2022)
7.8.5 Wonda Science Key News
7.9 Hangzhou Dayangchem
7.9.1 Hangzhou Dayangchem Corporate Summary
7.9.2 Hangzhou Dayangchem Business Overview
7.9.3 Hangzhou Dayangchem Matuzumab Major Product Offerings
7.9.4 Hangzhou Dayangchem Matuzumab Sales and Revenue in Global (2017-2022)
7.9.5 Hangzhou Dayangchem Key News
7.10 Leap Chem
7.10.1 Leap Chem Corporate Summary
7.10.2 Leap Chem Business Overview
7.10.3 Leap Chem Matuzumab Major Product Offerings
7.10.4 Leap Chem Matuzumab Sales and Revenue in Global (2017-2022)
7.10.5 Leap Chem Key News
7.11 Nantong Feiyu Biological Technology
7.11.1 Nantong Feiyu Biological Technology Corporate Summary
7.11.2 Nantong Feiyu Biological Technology Matuzumab Business Overview
7.11.3 Nantong Feiyu Biological Technology Matuzumab Major Product Offerings
7.11.4 Nantong Feiyu Biological Technology Matuzumab Sales and Revenue in Global (2017-2022)
7.11.5 Nantong Feiyu Biological Technology Key News
7.12 Ningbo Inno Pharmchem
7.12.1 Ningbo Inno Pharmchem Corporate Summary
7.12.2 Ningbo Inno Pharmchem Matuzumab Business Overview
7.12.3 Ningbo Inno Pharmchem Matuzumab Major Product Offerings
7.12.4 Ningbo Inno Pharmchem Matuzumab Sales and Revenue in Global (2017-2022)
7.12.5 Ningbo Inno Pharmchem Key News
7.13 Sichuan Weiqi Biotechnology
7.13.1 Sichuan Weiqi Biotechnology Corporate Summary
7.13.2 Sichuan Weiqi Biotechnology Matuzumab Business Overview
7.13.3 Sichuan Weiqi Biotechnology Matuzumab Major Product Offerings
7.13.4 Sichuan Weiqi Biotechnology Matuzumab Sales and Revenue in Global (2017-2022)
7.13.5 Sichuan Weiqi Biotechnology Key News
8 GLOBAL MATUZUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Matuzumab Production Capacity, 2017-2028
8.2 Matuzumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Matuzumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MATUZUMAB SUPPLY CHAIN ANALYSIS
10.1 Matuzumab Industry Value Chain
10.2 Matuzumab Upstream Market
10.3 Matuzumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Matuzumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Matuzumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Matuzumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MATUZUMAB OVERALL MARKET SIZE
2.1 Global Matuzumab Market Size: 2021 VS 2028
2.2 Global Matuzumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Matuzumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Matuzumab Players in Global Market
3.2 Top Global Matuzumab Companies Ranked by Revenue
3.3 Global Matuzumab Revenue by Companies
3.4 Global Matuzumab Sales by Companies
3.5 Global Matuzumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Matuzumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Matuzumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Matuzumab Players in Global Market
3.8.1 List of Global Tier 1 Matuzumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Matuzumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Matuzumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Matuzumab Revenue & Forecasts
4.2.1 By Type - Global Matuzumab Revenue, 2017-2022
4.2.2 By Type - Global Matuzumab Revenue, 2023-2028
4.2.3 By Type - Global Matuzumab Revenue Market Share, 2017-2028
4.3 By Type - Global Matuzumab Sales & Forecasts
4.3.1 By Type - Global Matuzumab Sales, 2017-2022
4.3.2 By Type - Global Matuzumab Sales, 2023-2028
4.3.3 By Type - Global Matuzumab Sales Market Share, 2017-2028
4.4 By Type - Global Matuzumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Matuzumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Matuzumab Revenue & Forecasts
5.2.1 By Application - Global Matuzumab Revenue, 2017-2022
5.2.2 By Application - Global Matuzumab Revenue, 2023-2028
5.2.3 By Application - Global Matuzumab Revenue Market Share, 2017-2028
5.3 By Application - Global Matuzumab Sales & Forecasts
5.3.1 By Application - Global Matuzumab Sales, 2017-2022
5.3.2 By Application - Global Matuzumab Sales, 2023-2028
5.3.3 By Application - Global Matuzumab Sales Market Share, 2017-2028
5.4 By Application - Global Matuzumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Matuzumab Market Size, 2021 & 2028
6.2 By Region - Global Matuzumab Revenue & Forecasts
6.2.1 By Region - Global Matuzumab Revenue, 2017-2022
6.2.2 By Region - Global Matuzumab Revenue, 2023-2028
6.2.3 By Region - Global Matuzumab Revenue Market Share, 2017-2028
6.3 By Region - Global Matuzumab Sales & Forecasts
6.3.1 By Region - Global Matuzumab Sales, 2017-2022
6.3.2 By Region - Global Matuzumab Sales, 2023-2028
6.3.3 By Region - Global Matuzumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Matuzumab Revenue, 2017-2028
6.4.2 By Country - North America Matuzumab Sales, 2017-2028
6.4.3 US Matuzumab Market Size, 2017-2028
6.4.4 Canada Matuzumab Market Size, 2017-2028
6.4.5 Mexico Matuzumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Matuzumab Revenue, 2017-2028
6.5.2 By Country - Europe Matuzumab Sales, 2017-2028
6.5.3 Germany Matuzumab Market Size, 2017-2028
6.5.4 France Matuzumab Market Size, 2017-2028
6.5.5 U.K. Matuzumab Market Size, 2017-2028
6.5.6 Italy Matuzumab Market Size, 2017-2028
6.5.7 Russia Matuzumab Market Size, 2017-2028
6.5.8 Nordic Countries Matuzumab Market Size, 2017-2028
6.5.9 Benelux Matuzumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Matuzumab Revenue, 2017-2028
6.6.2 By Region - Asia Matuzumab Sales, 2017-2028
6.6.3 China Matuzumab Market Size, 2017-2028
6.6.4 Japan Matuzumab Market Size, 2017-2028
6.6.5 South Korea Matuzumab Market Size, 2017-2028
6.6.6 Southeast Asia Matuzumab Market Size, 2017-2028
6.6.7 India Matuzumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Matuzumab Revenue, 2017-2028
6.7.2 By Country - South America Matuzumab Sales, 2017-2028
6.7.3 Brazil Matuzumab Market Size, 2017-2028
6.7.4 Argentina Matuzumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Matuzumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Matuzumab Sales, 2017-2028
6.8.3 Turkey Matuzumab Market Size, 2017-2028
6.8.4 Israel Matuzumab Market Size, 2017-2028
6.8.5 Saudi Arabia Matuzumab Market Size, 2017-2028
6.8.6 UAE Matuzumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Biosynth Carbosynth
7.1.1 Biosynth Carbosynth Corporate Summary
7.1.2 Biosynth Carbosynth Business Overview
7.1.3 Biosynth Carbosynth Matuzumab Major Product Offerings
7.1.4 Biosynth Carbosynth Matuzumab Sales and Revenue in Global (2017-2022)
7.1.5 Biosynth Carbosynth Key News
7.2 BOC Sciences
7.2.1 BOC Sciences Corporate Summary
7.2.2 BOC Sciences Business Overview
7.2.3 BOC Sciences Matuzumab Major Product Offerings
7.2.4 BOC Sciences Matuzumab Sales and Revenue in Global (2017-2022)
7.2.5 BOC Sciences Key News
7.3 Carbosynth
7.3.1 Carbosynth Corporate Summary
7.3.2 Carbosynth Business Overview
7.3.3 Carbosynth Matuzumab Major Product Offerings
7.3.4 Carbosynth Matuzumab Sales and Revenue in Global (2017-2022)
7.3.5 Carbosynth Key News
7.4 Merck KGaA
7.4.1 Merck KGaA Corporate Summary
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Matuzumab Major Product Offerings
7.4.4 Merck KGaA Matuzumab Sales and Revenue in Global (2017-2022)
7.4.5 Merck KGaA Key News
7.5 Shanghai Yifei Biotechnology
7.5.1 Shanghai Yifei Biotechnology Corporate Summary
7.5.2 Shanghai Yifei Biotechnology Business Overview
7.5.3 Shanghai Yifei Biotechnology Matuzumab Major Product Offerings
7.5.4 Shanghai Yifei Biotechnology Matuzumab Sales and Revenue in Global (2017-2022)
7.5.5 Shanghai Yifei Biotechnology Key News
7.6 Takeda Pharmaceutical
7.6.1 Takeda Pharmaceutical Corporate Summary
7.6.2 Takeda Pharmaceutical Business Overview
7.6.3 Takeda Pharmaceutical Matuzumab Major Product Offerings
7.6.4 Takeda Pharmaceutical Matuzumab Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Key News
7.7 TargetMol Chemicals
7.7.1 TargetMol Chemicals Corporate Summary
7.7.2 TargetMol Chemicals Business Overview
7.7.3 TargetMol Chemicals Matuzumab Major Product Offerings
7.7.4 TargetMol Chemicals Matuzumab Sales and Revenue in Global (2017-2022)
7.7.5 TargetMol Chemicals Key News
7.8 Wonda Science
7.8.1 Wonda Science Corporate Summary
7.8.2 Wonda Science Business Overview
7.8.3 Wonda Science Matuzumab Major Product Offerings
7.8.4 Wonda Science Matuzumab Sales and Revenue in Global (2017-2022)
7.8.5 Wonda Science Key News
7.9 Hangzhou Dayangchem
7.9.1 Hangzhou Dayangchem Corporate Summary
7.9.2 Hangzhou Dayangchem Business Overview
7.9.3 Hangzhou Dayangchem Matuzumab Major Product Offerings
7.9.4 Hangzhou Dayangchem Matuzumab Sales and Revenue in Global (2017-2022)
7.9.5 Hangzhou Dayangchem Key News
7.10 Leap Chem
7.10.1 Leap Chem Corporate Summary
7.10.2 Leap Chem Business Overview
7.10.3 Leap Chem Matuzumab Major Product Offerings
7.10.4 Leap Chem Matuzumab Sales and Revenue in Global (2017-2022)
7.10.5 Leap Chem Key News
7.11 Nantong Feiyu Biological Technology
7.11.1 Nantong Feiyu Biological Technology Corporate Summary
7.11.2 Nantong Feiyu Biological Technology Matuzumab Business Overview
7.11.3 Nantong Feiyu Biological Technology Matuzumab Major Product Offerings
7.11.4 Nantong Feiyu Biological Technology Matuzumab Sales and Revenue in Global (2017-2022)
7.11.5 Nantong Feiyu Biological Technology Key News
7.12 Ningbo Inno Pharmchem
7.12.1 Ningbo Inno Pharmchem Corporate Summary
7.12.2 Ningbo Inno Pharmchem Matuzumab Business Overview
7.12.3 Ningbo Inno Pharmchem Matuzumab Major Product Offerings
7.12.4 Ningbo Inno Pharmchem Matuzumab Sales and Revenue in Global (2017-2022)
7.12.5 Ningbo Inno Pharmchem Key News
7.13 Sichuan Weiqi Biotechnology
7.13.1 Sichuan Weiqi Biotechnology Corporate Summary
7.13.2 Sichuan Weiqi Biotechnology Matuzumab Business Overview
7.13.3 Sichuan Weiqi Biotechnology Matuzumab Major Product Offerings
7.13.4 Sichuan Weiqi Biotechnology Matuzumab Sales and Revenue in Global (2017-2022)
7.13.5 Sichuan Weiqi Biotechnology Key News
8 GLOBAL MATUZUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Matuzumab Production Capacity, 2017-2028
8.2 Matuzumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Matuzumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MATUZUMAB SUPPLY CHAIN ANALYSIS
10.1 Matuzumab Industry Value Chain
10.2 Matuzumab Upstream Market
10.3 Matuzumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Matuzumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Matuzumab in Global Market
Table 2. Top Matuzumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Matuzumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Matuzumab Revenue Share by Companies, 2017-2022
Table 5. Global Matuzumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Matuzumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Matuzumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Matuzumab Product Type
Table 9. List of Global Tier 1 Matuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Matuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Matuzumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Matuzumab Sales (Kg), 2017-2022
Table 15. By Type - Global Matuzumab Sales (Kg), 2023-2028
Table 16. By Application – Global Matuzumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Matuzumab Sales (Kg), 2017-2022
Table 20. By Application - Global Matuzumab Sales (Kg), 2023-2028
Table 21. By Region – Global Matuzumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Matuzumab Sales (Kg), 2017-2022
Table 25. By Region - Global Matuzumab Sales (Kg), 2023-2028
Table 26. By Country - North America Matuzumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Matuzumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Matuzumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Matuzumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Matuzumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Matuzumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Matuzumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Matuzumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Matuzumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Matuzumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Matuzumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Matuzumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Matuzumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Matuzumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Matuzumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Matuzumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Matuzumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Matuzumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Matuzumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Matuzumab Sales, (Kg), 2023-2028
Table 46. Biosynth Carbosynth Corporate Summary
Table 47. Biosynth Carbosynth Matuzumab Product Offerings
Table 48. Biosynth Carbosynth Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. BOC Sciences Corporate Summary
Table 50. BOC Sciences Matuzumab Product Offerings
Table 51. BOC Sciences Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Carbosynth Corporate Summary
Table 53. Carbosynth Matuzumab Product Offerings
Table 54. Carbosynth Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Merck KGaA Corporate Summary
Table 56. Merck KGaA Matuzumab Product Offerings
Table 57. Merck KGaA Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Shanghai Yifei Biotechnology Corporate Summary
Table 59. Shanghai Yifei Biotechnology Matuzumab Product Offerings
Table 60. Shanghai Yifei Biotechnology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Takeda Pharmaceutical Corporate Summary
Table 62. Takeda Pharmaceutical Matuzumab Product Offerings
Table 63. Takeda Pharmaceutical Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. TargetMol Chemicals Corporate Summary
Table 65. TargetMol Chemicals Matuzumab Product Offerings
Table 66. TargetMol Chemicals Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Wonda Science Corporate Summary
Table 68. Wonda Science Matuzumab Product Offerings
Table 69. Wonda Science Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Hangzhou Dayangchem Corporate Summary
Table 71. Hangzhou Dayangchem Matuzumab Product Offerings
Table 72. Hangzhou Dayangchem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Leap Chem Corporate Summary
Table 74. Leap Chem Matuzumab Product Offerings
Table 75. Leap Chem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Nantong Feiyu Biological Technology Corporate Summary
Table 77. Nantong Feiyu Biological Technology Matuzumab Product Offerings
Table 78. Nantong Feiyu Biological Technology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Ningbo Inno Pharmchem Corporate Summary
Table 80. Ningbo Inno Pharmchem Matuzumab Product Offerings
Table 81. Ningbo Inno Pharmchem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Sichuan Weiqi Biotechnology Corporate Summary
Table 83. Sichuan Weiqi Biotechnology Matuzumab Product Offerings
Table 84. Sichuan Weiqi Biotechnology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Matuzumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 86. Global Matuzumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Matuzumab Production by Region, 2017-2022 (Kg)
Table 88. Global Matuzumab Production by Region, 2023-2028 (Kg)
Table 89. Matuzumab Market Opportunities & Trends in Global Market
Table 90. Matuzumab Market Drivers in Global Market
Table 91. Matuzumab Market Restraints in Global Market
Table 92. Matuzumab Raw Materials
Table 93. Matuzumab Raw Materials Suppliers in Global Market
Table 94. Typical Matuzumab Downstream
Table 95. Matuzumab Downstream Clients in Global Market
Table 96. Matuzumab Distributors and Sales Agents in Global Market
Table 1. Key Players of Matuzumab in Global Market
Table 2. Top Matuzumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Matuzumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Matuzumab Revenue Share by Companies, 2017-2022
Table 5. Global Matuzumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Matuzumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Matuzumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Matuzumab Product Type
Table 9. List of Global Tier 1 Matuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Matuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Matuzumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Matuzumab Sales (Kg), 2017-2022
Table 15. By Type - Global Matuzumab Sales (Kg), 2023-2028
Table 16. By Application – Global Matuzumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Matuzumab Sales (Kg), 2017-2022
Table 20. By Application - Global Matuzumab Sales (Kg), 2023-2028
Table 21. By Region – Global Matuzumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Matuzumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Matuzumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Matuzumab Sales (Kg), 2017-2022
Table 25. By Region - Global Matuzumab Sales (Kg), 2023-2028
Table 26. By Country - North America Matuzumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Matuzumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Matuzumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Matuzumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Matuzumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Matuzumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Matuzumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Matuzumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Matuzumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Matuzumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Matuzumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Matuzumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Matuzumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Matuzumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Matuzumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Matuzumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Matuzumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Matuzumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Matuzumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Matuzumab Sales, (Kg), 2023-2028
Table 46. Biosynth Carbosynth Corporate Summary
Table 47. Biosynth Carbosynth Matuzumab Product Offerings
Table 48. Biosynth Carbosynth Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. BOC Sciences Corporate Summary
Table 50. BOC Sciences Matuzumab Product Offerings
Table 51. BOC Sciences Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Carbosynth Corporate Summary
Table 53. Carbosynth Matuzumab Product Offerings
Table 54. Carbosynth Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Merck KGaA Corporate Summary
Table 56. Merck KGaA Matuzumab Product Offerings
Table 57. Merck KGaA Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Shanghai Yifei Biotechnology Corporate Summary
Table 59. Shanghai Yifei Biotechnology Matuzumab Product Offerings
Table 60. Shanghai Yifei Biotechnology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Takeda Pharmaceutical Corporate Summary
Table 62. Takeda Pharmaceutical Matuzumab Product Offerings
Table 63. Takeda Pharmaceutical Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. TargetMol Chemicals Corporate Summary
Table 65. TargetMol Chemicals Matuzumab Product Offerings
Table 66. TargetMol Chemicals Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Wonda Science Corporate Summary
Table 68. Wonda Science Matuzumab Product Offerings
Table 69. Wonda Science Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Hangzhou Dayangchem Corporate Summary
Table 71. Hangzhou Dayangchem Matuzumab Product Offerings
Table 72. Hangzhou Dayangchem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Leap Chem Corporate Summary
Table 74. Leap Chem Matuzumab Product Offerings
Table 75. Leap Chem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Nantong Feiyu Biological Technology Corporate Summary
Table 77. Nantong Feiyu Biological Technology Matuzumab Product Offerings
Table 78. Nantong Feiyu Biological Technology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Ningbo Inno Pharmchem Corporate Summary
Table 80. Ningbo Inno Pharmchem Matuzumab Product Offerings
Table 81. Ningbo Inno Pharmchem Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Sichuan Weiqi Biotechnology Corporate Summary
Table 83. Sichuan Weiqi Biotechnology Matuzumab Product Offerings
Table 84. Sichuan Weiqi Biotechnology Matuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Matuzumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 86. Global Matuzumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Matuzumab Production by Region, 2017-2022 (Kg)
Table 88. Global Matuzumab Production by Region, 2023-2028 (Kg)
Table 89. Matuzumab Market Opportunities & Trends in Global Market
Table 90. Matuzumab Market Drivers in Global Market
Table 91. Matuzumab Market Restraints in Global Market
Table 92. Matuzumab Raw Materials
Table 93. Matuzumab Raw Materials Suppliers in Global Market
Table 94. Typical Matuzumab Downstream
Table 95. Matuzumab Downstream Clients in Global Market
Table 96. Matuzumab Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Matuzumab Segment by Type
Figure 2. Matuzumab Segment by Application
Figure 3. Global Matuzumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Matuzumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Matuzumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Matuzumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Matuzumab Revenue in 2021
Figure 9. By Type - Global Matuzumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Matuzumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Matuzumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Matuzumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Matuzumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Matuzumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Matuzumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Matuzumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Matuzumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Matuzumab Sales Market Share, 2017-2028
Figure 19. US Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Matuzumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Matuzumab Sales Market Share, 2017-2028
Figure 24. Germany Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Matuzumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Matuzumab Sales Market Share, 2017-2028
Figure 33. China Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Matuzumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Matuzumab Sales Market Share, 2017-2028
Figure 40. Brazil Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Matuzumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Matuzumab Sales Market Share, 2017-2028
Figure 44. Turkey Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Matuzumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Matuzumab by Region, 2021 VS 2028
Figure 50. Matuzumab Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Matuzumab Segment by Type
Figure 2. Matuzumab Segment by Application
Figure 3. Global Matuzumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Matuzumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Matuzumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Matuzumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Matuzumab Revenue in 2021
Figure 9. By Type - Global Matuzumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Matuzumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Matuzumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Matuzumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Matuzumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Matuzumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Matuzumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Matuzumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Matuzumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Matuzumab Sales Market Share, 2017-2028
Figure 19. US Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Matuzumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Matuzumab Sales Market Share, 2017-2028
Figure 24. Germany Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Matuzumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Matuzumab Sales Market Share, 2017-2028
Figure 33. China Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Matuzumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Matuzumab Sales Market Share, 2017-2028
Figure 40. Brazil Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Matuzumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Matuzumab Sales Market Share, 2017-2028
Figure 44. Turkey Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Matuzumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Matuzumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Matuzumab by Region, 2021 VS 2028
Figure 50. Matuzumab Industry Value Chain
Figure 51. Marketing Channels
